Arch Biopartners Announces Ethics Approval for St. Michael’s Hospital to Participate in the Phase II Cardiac Surgery-Associated AKI Trial for LSALT Peptide

With the UHN REB approval, issued through the Clinical Trials Ontario (CTO) Stream system, St. Michael’s Hospital in Toronto, Ontario will now proceed to complete operational approvals, training, and ...

Drug reduced need for blood transfusions during hospitalization for non-cardiac surgery

When hospitals were randomly assigned to treat patients undergoing higher-risk non-cardiac surgery with tranexamic acid (TXA) ...
Baylor College of Medicine

BCM to lead cardiac innovation AI-driven drug safety project

Baylor College of Medicine will be a site for a new multi-institution project aimed at investigating preclinical drug safety ...
MedPage Today

Colchicine Stumbles for Protecting the Heart From Thoracic Surgery

Clinically important Afib occurred in 6.4% of colchicine-treated patients and 7.5% of placebo recipients (HR 0.85, 95% CI 0.65-1.10, P=0.22), David Conen, MD, of the Population Health Research ...
News Medical

Human cell-based model of thoracic aortic aneurysm offers new opportunities for drug development

Using human cells in laboratory rats, Michigan Medicine researchers have developed a functional model of thoracic aortic aneurysm, creating opportunities for more effective understanding of disease ...